Simulation of quality-adjusted survival in chronic diseases: an application in type 2 diabetes.

Simulation of quality-adjusted survival in chronic diseases: an application in type 2 diabetes.

BACKGROUND: Recent studies have demonstrated that measures of health-related quality of life can predict complications and mortality in patients with diabetes, even after adjustment for clinical risk factors. METHODS: The authors developed a simulation model of disease progression in type 2 diabete...

Descripció completa

Dades bibliogràfiques
Autors principals:	Hayes, A, Clarke, P, Voysey, M, Keech, A
Format:	Journal article
Idioma:	English
Publicat:	2011

Ítems similars

Effects of Fenofibrate on Cardiovascular (CVD) Events in Patients with Type 2 Diabetes Mellitus (DM) after Adjustment for Statin Use and Other Drugs: the FIELD Study
per: Simes, J, et al.
Publicat: (2008)

Can self-rated health scores be used for risk prediction in patients with type 2 diabetes?
per: Hayes, A, et al.
Publicat: (2008)

Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes.
per: Clarke, P, et al.
Publicat: (2009)

Simulating lifetime outcomes associated with complications for people with type 1 diabetes.
per: Lung, T, et al.
Publicat: (2013)

Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohort.
per: Best, J, et al.
Publicat: (2012)

Quality Adjustment for Health Care Spending on Chronic Disease: Evidence from Diabetes Treatment, 1999–2009
per: Eggleston, Karen N, et al.
Publicat: (2014)

Simulation-Based Evaluation of Treatment Adjustment to Exercise in Type 1 Diabetes
per: Julia Deichmann, et al.
Publicat: (2021-08-01)

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial.
per: Rajamani, K, et al.
Publicat: (2009)

Association of weight-adjusted waist index and diabetic kidney disease in type 2 diabetes mellitus
per: Yunyi Ding, et al.
Publicat: (2024-03-01)

Financial Benefits of Renal Dose-Adjusted Dipeptidyl Peptidase-4 Inhibitors for Patients with Type 2 Diabetes and Chronic Kidney Disease
per: Hun Jee Choe, et al.
Publicat: (2024-08-01)

Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
per: Tonkin, A, et al.
Publicat: (2012)

Patient adjusted versus health professional adjusted insulin dosing for type 2 diabetes mellitus
per: Ng, C.J., et al.
Publicat: (2013)

Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort
per: Hiroshi Yokomichi
Publicat: (2017-03-01)

Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison
per: David Cherney, et al.
Publicat: (2024-07-01)

A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials.
per: Simes, J, et al.
Publicat: (2010)

ADVANTAGES, SAFETY AND PROSPECTS OF SITAGLIPTIN APPLICATION IN TYPE 2 DIABETES MELLITUS WITH CHRONIC KIDNEY DISEASE
per: I. A. Bonda
Publicat: (2017-07-01)

Effects of Chronic Diseases on Quality Adjusted Life Year and Economic Losses of the Elderly
per: Xinyue ZHAO, Xiao ZHENG, Yaqing XUE, Weiwei WU, Jiao LU, Chichen ZHANG
Publicat: (2022-07-01)

Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial
per: Maria-Pilar Barretina-Ginesta, et al.
Publicat: (2022-09-01)

Chronic inflammation and progression of chronic kidney disease in patients with type 2 diabetes
per: T. Mazur, et al.
Publicat: (2021-10-01)

Patient-adjusted versus health professional-adjusted insulin dosing for type 2 diabetes mellitus
per: Ng, Chirk Jenn, et al.
Publicat: (2018)

The relationship between weight-adjusted-waist index and diabetic kidney disease in patients with type 2 diabetes mellitus
per: Zhaoxiang Wang, et al.
Publicat: (2024-03-01)

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
per: Hayes, A, et al.
Publicat: (2013)

UKPDS Outcomes Model 2: A new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year united kingdom prospective diabetes Study: UKPDS 82
per: Hayes, A, et al.
Publicat: (2013)

P642: IMPACT OF TYPE 2 DIABETES ON SURVIVAL AND TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
per: E. Curovic Rotbain, et al.
Publicat: (2022-06-01)

Commentary: The relationship between weight-adjusted-waist index and diabetic kidney disease in patients with type 2 diabetes mellitus
per: Xiao Li, et al.
Publicat: (2024-06-01)

Management of type 2 diabetes in chronic kidney disease
per: Salim S Virani, et al.
Publicat: (2021-03-01)

Type 2 diabetes mellitus and multiple chronic diseases
per: Nailya S. Asfandiyarova, et al.
Publicat: (2018-12-01)

Correction: A Novel Method to Adjust Efficacy Estimates for Uptake of Other Active Treatments in Long-Term Clinical Trials.
per: John Simes, et al.
Publicat: (2010-01-01)

Relation between metacognitive beliefs and psychological adjustment with improving quality of life in type II diabetic patients
per: Anahita Khodabakhshi Koolaee, et al.
Publicat: (2019-10-01)

Dose adjustment of antidiabetic medications in chronic kidney disease
per: Matthew Salvatore Snyder, et al.
Publicat: (2021-01-01)

Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease).
per: Lynda A Szczech, et al.
Publicat: (2014-01-01)

Treatment of Patients Chronic Coronary Heart Disease and Type 2 Diabetes Mellitus
per: E. V. Shсhukina, et al.
Publicat: (2023-04-01)

Chronic renal disease in patients with type 2 diabetes mellitus
per: Nane E. Khachaturian
Publicat: (2019-06-01)

Heart Failure and Chronic Kidney Disease in Type 2 Diabetes
per: Cernea Simona
Publicat: (2016-12-01)

Type 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases
per: Marine M. Tanashyan, et al.
Publicat: (2021-10-01)

Chronic obstructive pulmonary disease and type 2 diabetes mellitus – diseases with cytokine imbalance
per: L. N. Sorokina, et al.
Publicat: (2024-10-01)

Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes
per: Khalid Siddiqui, et al.
Publicat: (2022-12-01)

A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials.
per: John Simes, et al.
Publicat: (2010-01-01)

Survival of type 1 diabetes mellitus patients on disease control programme
per: Ronald Wesonga, et al.
Publicat: (2024-09-01)

Cerebral hemodynamics in patients with type 2 diabetes mellitus and chronic kidney disease
per: A.Yu. Kholikov, et al.
Publicat: (2021-10-01)